register

News & Trends - Pharmaceuticals

PAIG co-chairs shed a light on the need to link diversity and inclusion to business performance

Health Industry Hub | November 7, 2022 |

Pharma News: Medicine Australia’s PAIG (Pharma Australia Inclusion Group) co-chairs Fiona Sheppard, DE&I Leader at J&J Family of Companies and Lee Davelaar, Strategic Policy Manager at Pfizer joined Health Industry Hub to share their insights and perspectives on the recently released The Future of Workplace Inclusion whitepaper.

In reflecting on the complexity of diversity, equity and inclusion (DE&I), Lee said “It’s so important that we start understanding the different complexities of our individuals that we work with and make sure that the programmes are truly in place to support them – whether they are working remotely or whether they are at the office, they are feeling that their identity is heard and that they’re feeling that they belong.”

Fiona commented on the DE&I journey that PAIG companies have undertaken. She said “We don’t exist within a vacuum. So it’s really important that we had case studies in there [whitepaper] that were outside of the industry because we also really need to test ourselves and ask ‘Are we doing the best that we can do? Can we do better and what does best practice looks like?”

Troy Roderick, a DE&I expert and Honorary Associate of the University Of Sydney Business School, challenged the pharma industry at the launch of the whitepaper.

Lee said “He told us it’s okay to link diversity and inclusion to commercial outcomes. Previously, there’s been a reluctance in talking about commercial outcomes and having DE&I linked to that. The best organisations that truly embed diversity and inclusion can understand how it works for employee retention, how it works for attracting the best talent and therefore how they’re able to perform as a result. I think that’s something we have to get more comfortable with when we look at DE&I programs across the board.”

Jennifer Jones, Head of Human Resources, Oceania at Takeda will take over as PAIG co-chair as a result of Fiona stepping down. In acknowledging their PAIG partnership, Lee said “I will truly miss working with her [Fiona] on such a regular basis. Considering we came into this role not knowing each other, and where our friendship has developed over those two years, her warmth, her sense of humour and her dedication to DE&I has been truly inspirational. I’ve certainly learned a wealth of knowledge about diversity and inclusion from working with Fi and I’ve enjoyed every minute of it.”

In reimagining healthcare across the entire patient journey, Health Industry HubTM is the only one-stop-hub uniting the diversity of the Pharma, MedTech, Diagnostics & Biotech sectors to inspire meaningful change.

The Health Industry HubTM content is copyright protected. Access is available under individual user licenses. Please click here to subscribe and visit T&Cs here.


News & Trends - Biotechnology

CSL reshapes R&D while bracing for U.S. tariffs

CSL reshapes R&D while bracing for U.S. tariffs

Health Industry Hub | July 11, 2025 |

Australia’s largest biotech company CSL is streamlining its R&D operations to enhance efficiency amidst a rapidly evolving global landscape. The […]

More


News & Trends - MedTech & Diagnostics

Australia joins Medtronic trial in fight against resistant hypertension

Australia joins Medtronic trial in fight against resistant hypertension

Health Industry Hub | July 11, 2025 |

Medtronic has launched an international clinical trial across Australia, the United States, and Europe to evaluate the feasibility of multi-organ […]

More


News & Trends - MedTech & Diagnostics

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban

Medibank launches pharmacogenetic testing while government stalls on insurance discrimination ban

Health Industry Hub | July 11, 2025 |

Medibank has become the first Australian health insurer to pay towards pharmacogenetic testing (PGx) for eligible customers on Extras cover. […]

More


News & Trends - Pharmaceuticals

Global pledge shifts visibility and action for patients with advanced breast cancer

Global pledge shifts visibility and action for patients with advanced breast cancer

Health Industry Hub | July 11, 2025 |

Three breast cancer organisations have united internationally to demand that people living with metastatic breast cancer (MBC) are no longer […]

More


This content is copyright protected. Please subscribe to gain access.